TEXAS MAN ADMITS DISTRIBUTION OF STEROIDS OVER THE INTERNET
Nora R. Dannehy, Acting United States Attorney for the District of Connecticut, announced that COREY L. STANFORD, JR., 31, of Austin, Texas, pleaded guilty today before United States District Judge Janet C. Hall in Bridgeport to one count of distributing anabolic steroids.
(Media-Newswire.com) - Nora R. Dannehy, Acting United States Attorney for the District of Connecticut, announced that COREY L. STANFORD, JR., 31, of Austin, Texas, pleaded guilty today before United States District Judge Janet C. Hall in Bridgeport to one count of distributing anabolic steroids.
According to documents filed with the Court and statements made in court, STANFORD used the Internet, including the website sell.com, to communicate with individuals interested in buying steroids. STANFORD then sent the steroids to those individuals through the mail.
This matter stems from Operation Phony Pharm, an investigation headed by the FBI’s Healthcare Fraud Unit in the District of Connecticut. Using several sophisticated investigative techniques, this initiative has targeted web sites and individuals who are selling Schedule II and III pharmaceuticals over the Internet without a doctor’s consultation or a legitimate legal written prescription. The investigation also sought to identify and close down underground laboratories in the U.S. that are making these drugs from raw materials obtained from outside the U.S.
Judge Hall has scheduled sentencing for July 7, 2008, at which time STANFORD faces a maximum term of imprisonment of five years and a fine of up to $250,000.
This matter is being investigated by the Federal Bureau of Investigation, the United States Postal Inspection Service, the Food and Drug Administration’s Office of Criminal Investigations, and the Drug Enforcement Administration. The case is being prosecuted by Assistant United States Attorney Edward Chang.
Related Content
Release Date
This story was released on 2008-04-23. Please make sure to visit the official company or organization web site to learn more about the original release date. See our disclaimer for additional information.